Zimmer Biomet Holdings, Inc. ZBH recently received ... Oxford Cementless Partial Knee has become the only FDA-approved cementless partial knee implant in the United States. The latest FDA PMA ...

Zimmer Biomet Holdings, Inc. ZBH is scheduled to report fourth-quarter 2024 results on Feb. 6, before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. In the last ...

The deal will give Zimmer Biomet access to Paragon's surgical implants and equipment used to treat foot and ankle ailments, while bolstering its fracture and trauma, and joint replacement businesses.

Zimmer Biomet’s Cian Kelly spoke to ... Kelly spoke about the rewarding work they do around creating knee and hip implants at the Galway site. “Everybody knows someone who has a knee implant ...

Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 ...

Zimmer Biomet Holdings ... a total knee implant component, and FDA’s premarket application supplement approval for the Oxford Cementless Partial Knee. These developments might have had a ...